MIMETAS B.V.
History
| Year | Detail |
|---|---|
| 2013 | Paul, Jos, and Bas founded MIMETAS in 2013 Leiden, the Netherlands. |
| 2019 | MIMETAS and Hubrecht Organoid Technology (HUB) collaborated to market organoid models on a Chip and develop disease-specific models. |
| 2021 | MIMETAS and Roche, a pharmaceutical company, collaborated to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). |
| 2023 | The company partnered with Astellas Pharma Inc. to support the next generation of immuno-oncological therapies. |
